Back to Journals » Journal of Inflammation Research » Volume 3

Emerging therapies for treatment of multiple sclerosis

Authors Corboy J, Miravalle AA

Published 23 July 2010 Volume 2010:3 Pages 53—59

DOI https://doi.org/10.2147/JIR.S6558

Review by Single-blind

Peer reviewer comments 5


John R Corboy, Augusto A Miravalle

Rocky Mountain Multiple Sclerosis Center, Anschutz Medical Campus, University of Colorado Denver, Aurora, Colorado, USA

Abstract: In the last decade, a new armamentarium of immune-based therapies have been developed and tested in patients with multiple sclerosis. Some of these therapies are showing a high level of efficacy, with an acceptable adverse effect profile. Because present therapies have significant limitations in slowing disease progression, require injections, are sometimes associated with significant side effects of immunosuppression, and do little to reverse disability, identifying more effective treatments is an important goal for clinical research in multiple sclerosis. However, in order to improve our current approach to disease-modifying therapies, it is imperative to promote the development of individualized therapy strategies.

Keywords: multiple sclerosis, lymphocyte-targeted therapy, immune sequestration, non-specific immune modulation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]